13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Latham & Watkins Advises on Acumen’s Upsized US$130 Million Public Offering
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs)…
Latham & Watkins Advises Gossamer Bio in US$212 Million Private Placement Financing
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment…
Latham Advises LEONI AG on the Successful Restructuring and Implementation of the Restructuring Plan Through StaRUG Proceedings
Latham & Watkins has advised LEONI AG, an international Tier 1 automotive supplier, on the successful restructuring and refinancing of…
Latham & Watkins Advises Cadence in Acquisition of Rambus PHY IP Assets
Cadence Design Systems, Inc. (Nasdaq: CDNS) and Rambus Inc. (Nasdaq: RMBS), a premier chip and silicon IP provider making data…
Hogan Lovells advising Tikehau Capital on its acquisition of a majority stake in CROWD
Global law firm Hogan Lovells is advising Tikehau Capital, a global alternative asset manager, on its acquisition of a majority…
Hogan Lovells secures victory preserving more than US$42 million for the war in Ukraine
A litigation team from Global law firm Hogan Lovells has secured a significant victory in the United States District Court…
